Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations
Children's National · The University of Texas Southwestern Medical Center · +11 more institutions
Indexed incrossrefdatacitepubmed
Abstract
No abstract available for this paper.
Citation impact
530
total citations
- FWCI
- 32.02
- Percentile
- 100%
- References
- 34
Citations per year
Authors
20Topics & keywords
Topics
Keywords
- Omalizumab
- Medicine
- Exacerbation
- Placebo
- Asthma
- Corticosteroid
- Internal medicine
- Rhinovirus
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- UDU.S. Department of Health and Human ServicesAwards: HHSN272201000052I, HHSN272200900052C
- NINational Institutes of Health
- NINational Institute of Allergy and Infectious DiseasesAwards: 5R01AI098077, UM1AI109565
- NCNational Center for Research Resources
- NCNational Center for Advancing Translational SciencesAwards: UL1TR000040, UL1TR000075, 1UL1RR025780, UL1TR000150, UL1 TR000154, NCRR / NIH UL1TR000451, UL1TR001105, UL1 TR000077-04